PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.51%
Revenue growth 10-15% – Solid pace. Seth Klarman would see if consistent expansion is reflected in improving net margins.
-3.51%
Gross profit growth 10-15% – Solid. Seth Klarman would see if consistent improvements are driven by genuine pricing power.
2.36%
EBIT growth 10-15% – Solid. Seth Klarman would see if this level of profit expansion is sustainable across cycles.
2.36%
Operating income growth 10-15% – Solid. Seth Klarman would look at whether overhead costs remain controlled for long-term stability.
30.03%
Net income growth 10-15% – Solid. Seth Klarman would verify if cost control or pricing is driving consistent profit expansions.
30.01%
EPS growth 10-15% – Solid. Seth Klarman would see if share dilution or buybacks significantly affected the results.
30.13%
Diluted EPS growth 10-15% – Solid. Seth Klarman would check if share-based compensation is offsetting part of net income gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-47.27%
OCF growth 10-15% – Solid. Seth Klarman would check consistency across several periods to confirm it’s not a one-off spike.
-47.27%
FCF growth 10-15% – Solid. Seth Klarman would confirm consistency and see if the firm reinvests or returns capital effectively.
1.28%
10Y revenue/share CAGR 7-10% – Solid. Seth Klarman would see if this consistent growth is accompanied by healthy free cash flow.
1.28%
5Y CAGR 7-10% – Solid. Seth Klarman might check if free cash flow growth parallels top-line expansion.
1.28%
3Y CAGR 5-10% – Decent. Seth Klarman would look for consistency, ensuring no large spike from a single year.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
40.81%
10Y net income/share CAGR 7-10% – Solid. Seth Klarman might check if dividends or buybacks accompany the rising profits.
40.81%
5Y net income/share CAGR 7-10% – Decent. Seth Klarman would investigate cyclical recovery vs. stable expansions.
40.81%
3Y net income/share CAGR 5-10% – Reasonable. Seth Klarman would check if it’s consistent each year or if one year skews the average.
8.27%
10Y equity/share CAGR 5-8% – Decent. Seth Klarman would check the firm’s ROE to ensure it aligns with this book value expansion.
8.27%
5Y equity/share CAGR 5-8% – Solid. Seth Klarman checks if ROE remains healthy during these mid-term expansions.
8.27%
3Y equity/share CAGR 5-8% – Solid. Seth Klarman might see a healthy short-term ROE fueling book value growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.58%
Asset growth 10-15% – Moderate. Seth Klarman sees if expansions or new facilities can increase ROA in tandem.
0.57%
5-8% annual BV/share growth – Decent. Seth Klarman monitors if ROE supports continued expansions.
1.03%
Debt growth between 0% and -5% – Slight reduction or flat. Seth Klarman considers it manageable leverage if cash flows stay robust.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.